Is shoulder pain a precursor to liver cancer?

According to your description, there are many reasons for shoulder pain. Sometimes, cervical spondylosis or frozen shoulder can cause it. So it is recommended that you go to the hospital for a comprehensive examination and pay attention to regular diet and work and rest habits. The initial symptoms of liver cancer patients are generally manifested as dull pain and discomfort in the liver area. When pain symptoms in other parts occur, it is already in the middle and late stages of liver cancer, and obvious clinical symptoms will appear. The painful part of the skin on the surface of the body is often the part of the skin that is injured, but the pain caused by visceral lesions is not as accurate as the pain caused by the skin on the surface of the body.

Dietary care for patients with advanced liver cancer

What should patients with advanced liver cancer pay attention to in terms of diet? Specifically, there are the following points: low-fat problem. Due to poor liver function, patients at this stage often cannot tolerate fat, so it is not recommended to eat broth, such as chicken soup, pork rib soup, etc. Protein problem. If the patient's protein intake is too low, it will be detrimental to the patient's recovery. If the protein intake is too high, some patients may experience hepatic coma, so the patient's protein intake should be small, balanced and moderate. Patients with advanced liver cancer often have diarrhea, bleeding gums, drowsiness, and feel weak and powerless, so they should pay more attention to their diet.

Survival rate of early-stage liver cancer treated with interventional therapy

The five-year survival rate of patients with liver cancer who receive interventional treatment can reach 10% to 30%. If interventional treatment is chosen for liver cancer, it means that the stage is relatively late, the lesions are relatively large, or multiple metastases have occurred in the liver. It can slow down the growth of tumor cells to a certain extent, and intervention can be performed in stages. At present, the two-year survival rate of patients with early liver cancer who receive transcatheter arterial chemoembolization can reach more than 65%. If combined with liver lesion ablation or local injection of anhydrous ethanol, more effective results can be achieved, and the three-year survival rate can reach more than 75%, which has the same therapeutic effect as surgical resection. It depends on the clinical stage of liver cancer.